BAYCOL (or Lipobay and Cerivastatin) is a drug used to lower LDL (bad) cholesterol levels, thereby reducing the probability of a heart attack. Baycol belongs to a class of drugs known as statins that are designed to block the production of an enzyme that generates LDL.

It is very powerful and is therefore prescribed in low doses of 0.4 and 0.8 milligrams (mg). Baycol was released in the United States in 1997 by Bayer AG, an enormous German conglomerate that manufactures chemicals and pharmaceuticals for global distribution.

By 1998, reports were being forwarded from physicians indicating adverse side effects from Baycol. In 1999, the Food and Drug Administration (FDA) approved the use of a potent dosage (0.4 mg) of Baycol. Several million people worldwide were taking ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles